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Mutations in the 30-50 exonuclease DIS3L2 are asso-
ciated with Perlman syndrome and hypersuscepti-
bility to Wilms tumorigenesis. Previously, we found
that Dis3l2 specifically recognizes and degrades
uridylated pre-let-7 microRNA. However, the wide-
spread relevance of Dis3l2-mediated decay of uridy-
lated substrates remains unknown. Here, we applied
an unbiased RNA immunoprecipitation strategy to
identify Dis3l2 targets in mouse embryonic stem
cells. The disease-associated long noncoding RNA
(lncRNA) Rmrp, 7SL, as well as several other Pol III-
transcribed noncoding RNAs (ncRNAs) were among
the most highly enriched Dis3l2-bound RNAs.
30-Uridylated Rmrp, 7SL, and small nuclear RNA
(snRNA) species were highly stabilized in the cyto-
plasm of Dis3l2-depleted cells. Deep sequencing
analysis of Rmrp 30 ends revealed extensive oli-
gouridylation mainly on transcripts with imprecise
ends. We implicate the terminal uridylyl transfer-
ases (TUTases) Zcchc6/11 in the uridylation of
these ncRNAs, and biochemical reconstitution as-
says demonstrate the sufficiency of TUTase-Dis3l2
for Rmrp decay. This establishes Dis3l2-mediated
decay (DMD) as a quality-control pathway that elim-
inates aberrant ncRNAs.INTRODUCTION
Dis3l2 is a mammalian exosome-independent homolog of
yeast Dis3, with 30-50 exoRNase activity. We, and others, previ-
ously identified Dis3l2 as the exonuclease that functions in the
Lin28-mediated repression and degradation of let-7 microRNAs
(miRNAs) in mouse embryonic stem cells (mESCs) (Chang et al.,
2013; Ustianenko et al., 2013). Lin28 recruits the terminal uridylyl
transferases (TUTases) Zcchc6 (TUT7) and Zcchc11 (TUT4) to
target precursor let-7 (pre-let-7) RNAs for degradation by
Dis3l2 (Hagan et al., 2009; Heo et al., 2009; Lin and Gregory,
2015; Thornton et al., 2012). Biochemical and structural studies
revealed that a stretch of oligo-uridylation (12 uridines) at the 30Cell Re
This is an open access article under the CC BY-Nend of transcripts serves as the recognition signal for Dis3l2 to
bind and degrade substrate RNAs (Chang et al., 2013; Faehnle
et al., 2014). Mutations in DIS3L2 are involved in the Perlman
overgrowth and Wilms tumor predisposition syndrome (Astuti
et al., 2012). Moreover, DIS3L2 mutations or deletions have
been reported in sporadic Wilms tumors (Astuti et al., 2012; Mor-
ris et al., 2013; Wegert et al., 2015). Despite these strong links
between DIS3L2 deficiency and human disease, very little is
known about the role of Dis3l2 in RNA regulation and specifically
the identity of its direct targets has so far remained elusive.
Although deep sequencing analysis has shown changes in
mRNA expression in Dis3l2-depleted human cells (Lubas et al.,
2013), it is not clear whether this reflects a direct and/or indirect
consequence of Dis3l2 loss. Indeed, Dis3l2 has been largely
eliminated as a possible regulator of uridylated histone mRNAs
as well as other mRNAs with short U-tails (Lim et al., 2014; Slevin
et al., 2014). Dis3l2 has been recently implicated in apoptosis-
induced mRNA degradation (Thomas et al., 2015), as well as
target RNA-directed miRNA degradation (TDMD) (Haas et al.,
2016). So far, a systematic identification of Dis3l2 direct targets
has not been performed and the repertoire of regulated RNAs re-
mains unknown.
The RNA polymerase (Pol) III transcriptome (also called class
III genes) includes a growing list of genes. Originally, RNA Pol
III was considered specialized for transcription of highly abun-
dant tRNAs and 5S rRNA species, which are engaged in protein
synthesis. However, over the past several years, RNA Pol III has
been reported to be responsible for transcription of many other
noncoding RNAs (ncRNAs). These ncRNAs include RNase
MRP (Rmrp), RNase P (Rpph1), U6 small nuclear RNA (snRNA),
7SL, 7SK, BC200, Vault, short interspersed repeated DNA ele-
ments (SINE)-encoded RNAs, as well as small nucleolar (sno)
RNAs, and some miRNAs (for review see Dieci et al., 2007). Pol
III-mediated transcription can be launched through a variety of
internal promoter elements, box A and box B, or box C (for 5S
rRNA), as well as upstream TATA (like)-box, proximal and/or
distal sequence elements or their combinations (for 7SK,
Rmrp, and Rpph1). In contrast, eukaryotic RNA Pol III terminates
transcription uniquely at a short stretch of thymidine (oligo-T)
residues on the non-templated strand of DNA and following
synthesis of a short uridine stretch (U-stretch) on nascent RNA
(Bogenhagen and Brown, 1981; Matsuzaki et al., 1994). This
oligo-T transcription termination signal serves both as recogni-
tion and pause signal (Arimbasseri and Maraia, 2015; Bragliaports 16, 1861–1873, August 16, 2016 ª 2016 The Author(s). 1861
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
et al., 2005; Nielsen et al., 2013; Orioli et al., 2012), which allows
the release of nascent RNA and polymerase fromDNA due to the
low stability of oligo (dA:rU) DNA:RNAduplex (Martin and Tinoco,
1980). Efficient termination can be achieved with the minimal
length of 4 or 5 Us at the 30 end of the transcripts in vertebrates
and yeast, respectively (Allison and Hall, 1985; Braglia et al.,
2005). RNA Pol III termination results in the incorporation of a
variable length oligo-U tract at the 30 end of the Pol III-primary
transcripts. For tRNAs, these 30 trailers are removed post-tran-
scriptionally by RNase Z that together with other exonucleases
generate the 30 end of themature tRNA (Maraia and Lamichhane,
2011). While extended transcription beyond termination signal
may provide developmental advantages (Orioli et al., 2011),
failure in trailer trimming can also be implicated in disease devel-
opment (Haack et al., 2013). Moreover, upon Pol III-induced
read-through of the genomic DNA, the unprocessed 30 oligo-U
tract may hybridize with internal sequences and interfere with
proper folding and abrogate the function of Pol III transcripts.
Rmrp is a highly conserved long noncoding RNA (lncRNA) with
endoRNase activity (Hsieh et al., 1990). Historically, Rmrp was
described as a ‘‘Ribozyme,’’ i.e., an RNA molecule with enzy-
matic activity (Kruger et al., 1982). It forms a ribonucleoprotein
complex that is well-characterized in different organisms (Fager-
lund et al., 2015; Gold et al., 1989; Lygerou et al., 1994). Reces-
sive mutations in human RMRP cause cartilage-hair hypoplasia
(CHH) (Ridanpa¨a¨ et al., 2001) with a wide range of manifestations
including short stature, anemia, immune deficiency, impaired
spermatogenesis, increased rate of skin cancer, and metaphy-
seal dysplasia (Ma¨kitie, 1992; Ma¨kitie et al., 1999, 2001; Trojak
et al., 1981). Studies in yeast models suggested that Rmrp is
involved in pre-rRNA processing (Chu et al., 1994) and 50 UTR
cleavage of cyclin B2 mRNA (Cai et al., 2002; Gill et al., 2004);
however, the exact role of Rmrp in vertebrates remains to
be elucidated (Huang et al., 2015). An increasing number of
RMRP mutations are reported that cause CHH in various popu-
lations (Bonafe´ et al., 2005; Cherkaoui Jaouad et al., 2015; Thiel
et al., 2007). RMRP is a highly structured RNA, in which muta-
tion-induced perturbations throughout most of 265 nucleotides
of human transcript are associated with different aspects of
CHH. This highlights the significance of retaining intact tran-
scripts in cells and suggests a demand for, as yet unknown,
Rmrp-associated quality control pathway(s).
Here, we performed a systematic analysis of RNAs that asso-
ciate with a catalytically inactive version of Dis3l2 isolated from
Dis3l2-deficient mouse ESCs. This revealed Dis3l2 targets to
be highly enriched for RNA Pol III-transcribed ncRNAs including
Rmrp, 7SL, and several others. Using CRISPR/Cas9 knockout
and RNAi-mediated knockdown approaches, we find that
Dis3l2 loss-of-function causes the stabilization of 30-uridylated
Rmrp, 7SL, and snRNAs species in the cell cytoplasm. Deep
sequencing analysis of Rmrp 30 ends from Dis3l2 knockout cells
revealed extensive oligouridylation mainly on Rmrp transcripts
with imprecise terminated ends supporting that Dis3l2 normally
safeguards the elimination of these aberrant Rmrp transcripts.
We identify the paralogous TUTases Zcchc6 and Zcchc11
to be responsible for ncRNA uridylation and reconstitute the
TUTase-Dis3l2 decay in vitro using recombinant proteins. Unlike
mRNA quality control pathways including nonsense-mediated1862 Cell Reports 16, 1861–1873, August 16, 2016decay (NMD) that require mRNA translation, we identify Dis3l2-
mediated decay (DMD) as a quality control pathway that elimi-
nates aberrant ncRNAs.
RESULTS
Global Identification of Dis3l2 Target RNAs
To explore the widespread relevance of Dis3l2 in the control of
RNA metabolism, we established a biochemical method for
the unbiased identification of Dis3l2 targets. This involved the
generation of Dis3l2 knockout ESCs (to stabilize labile Dis3l2
substrates) and the expression of a catalytically inactive Dis3l2
that retained its RNA-binding capability (to identify direct
Dis3l2 substrate RNAs). We used the CRISPR/Cas9 editing sys-
tem to generate Dis3l2 knockout mouse ESCs (Figure S1A).
Deletion of Dis3l2 genomic DNA and subsequently loss of
protein expression in knockout ESCs was confirmed by PCR
(Figure S1B) and western blot analysis (Figures 1A and S1C),
respectively. Dis3l2/ ESCs were transfected with a plasmid
for expression of a catalytic mutant FLAG-tagged Dis3l2
(D389N substitution) that we previously showed can bind but
not degrade RNA (Chang et al., 2013). Moreover, the relative
expression level and subcellular localization of the catalytic
mutant Dis3l2 is comparable to the wild-type protein when
ectopically expressed (Chang et al., 2013). Potential Dis3l2 sub-
strates were immunoprecipitated (IP) using anti-FLAG antibody
(Figure 1B). As a negative control, cells were transfected in par-
allel with FLAG-empty vector (Mock). The precipitated Dis3l2
ribonucleoprotein complexes were reverse cross-linked and
RNA was isolated and sequenced (RNA immunoprecipitation
[RIP]-seq) (Table S1). A scatter plot of the RIP-seq data revealed
a significant enrichment of several transcripts in mutant FLAG-
Dis3l2 IP (Figure 1C). Among the highly enriched transcripts
were the lncRNA components of the two related ribozymes:
RNase MRP (Rmrp) and RNase P (Rpph1) as well as the two
Rpph1 pseudogenes, Rprl2 and Rprl3. (Figures 1C and 1D).
Rmrp and Rpph1 are two ubiquitously expressed conserved
RNA Pol III-transcribed lncRNAs with enzymatic activity and
are highly expressed in various cell types. In contrast to Rmrp
and Rpph1, other transcripts with even higher abundance,
Malat1 and Lars2, were not enriched in Dis3l2-RIP (Figures 1C
and 1E), supporting the specificity of these interactions. Inde-
pendent immunoprecipitation of mutant FLAG-Dis3l2 followed
by qRT-PCR showed a significant enrichment of these two
lncRNAs, especially Rmrp (Figure 1E). Finally, qRT-PCR analysis
of immunoprecipitated RNA samples (Figure 1F) showed a
strong enrichment of Rmrp in mutant FLAG-Dis3l2 but not
wild-type FLAG-Dis3l2 IPs (Figure 1G).
Uridylated Rmrp Accumulates in the Cytoplasm of
Dis3l2-Depleted ESCs
We reasoned that if Dis3l2 is involved in the 30-50 decay of its
substrates, uridylated species of Rmrp and Rpph1 should accu-
mulate in Dis3l2-deficient cells. To quantify the relative uridyla-
tion of different transcripts, cDNA synthesis was performed
using oligo-dA(12) primers that enriched specifically for uridylated
RNA species. While the relative expression of Rmrp measured
by qRT-PCR analysis of random hexamer-primed cDNA was
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Figure 1. Systematic Identification of Dis3l2-Associated RNAs in Mouse ESCs
(A) Western blot analysis of Dis3l2 expression in CRISPR-Cas9 generated knockout ESCs. WT, wild-type; Het, heterozygous; KO, knockout.
(B) Western blot analysis of FLAG-tagged Dis3l2 in input and IP samples. Arrow points to the FLAGmutant Dis3l2 expression in knockout ESCs (Inputs) and after
anti-FLAG immunoprecipitation (IPs). Asterisk shows an unspecific band, representing equal loading. Empty pFLAG-CMV2 vector was used as mock.
(C) Scatter plotting of enriched transcripts in FLAG mutant Dis3l2 IP compared to Mock IP. Among the most enriched transcripts are Rmrp, Rpph1, and the two
Rpph1 pseudogenes, Rprl2 and Rprl3, all highlighted in red.
(D) Representative sequencing track of Rmrp and Rpph1 in inputs and IPs. Read numbers range from 0–3,500.
(E) qRT-PCR analysis of FLAG-immunoprecipitated RNAs (n = 6). Note that Malat1 was not enriched in FLAGmutant Dis3l2 IP. Tomeasure relative enrichment of
each gene, expressions in IP samples were first normalized to Gapdh level and then to the respective input. ns, not significant.
(F) Anti-FLAG immunoblotting of Dis3l2 knockout cellular lysates after overexpression of WT, mutant Dis3l2, or mock transfected cells as well as related
immunoprecipitation.
(G) qRT-PCR analysis of FLAG-immunoprecipitated RNAs. Oligo-dA primers were used for cDNA synthesis after RNA-IP to measure relative uridylation levels
(n = 6). ns, not significant. Where related, scale bars represent mean ± SEM. **p% 0.01, ***p% 0.001, Student’s t test.
See also Figure S1 and Table S1.only increased modestly (Figure 2A), a marked increase in rela-
tive Rmrp and pre-let-7g uridylation was observed in Dis3l2
knockout cells compared to heterozygous and wild-type ESC
controls (Figure 2B). This suggests a posttranscriptional regula-
tion of Rmrp and pre-let-7g. Neither relative uridylation nor
expression of Rpph1 and Sox2 changed in Dis3l2 knockoutESCs. To further confirm these findings, we knocked down
Dis3l2 in ESCs using shRNA and measured relative expression
and uridylation levels (Figure S2). Consistent with the results in
knockout cells, the level of uridylated Rmrp, but not Rpph1,
increased in a dose-dependent manner in the shDis3l2 stable
knockdown ESCs (Figures S2A–S2C). Transient knockdown ofCell Reports 16, 1861–1873, August 16, 2016 1863
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Figure 2. Uridylated Rmrp Transcripts Accumulate in the Cytoplasm of Dis3l2-Deficient ESCs
(A) qRT-PCR analysis of total gene expression in Dis3l2 knockout ESCs (n = 4).
(B) Increased relative uridylation of Rmrp and pre-let7g, but not Rpph1 or Sox2 in Dis3l2-depleted ESCs (n = 4).
(legend continued on next page)
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Dis3l2 using siRNA showed a similar effect on Rmrp uridyla-
tion (Figures S2D–S2F). Thus, the level of uridylated Rmrp is
increased substantially in the absence of Dis3l2. Dis3l2 rescue
experiments were performed by transfecting wild-type FLAG-
Dis3l2 expression plasmids in Dis3l2-knockout ECSs. Western
blot analysis showed the expression of Dis3l2 in knockout
cells similar to the endogenous levels in wild-type ESCs (Fig-
ure 2C). qRT-PCR analysis showed a dramatic accumulation of
uridylated Rmrp and pre-let-7g in Dis3l2 knockout ESCs that
was significantly reduced upon transient transfection of Dis3l2
(Figure 2D).
Rmrp is amostly nuclear RNA (Jacobson et al., 1995), whereas
Dis3l2 is mainly localized to the cytoplasm (Chang et al., 2013;
Lubas et al., 2013; Ustianenko et al., 2013). It is therefore
anticipated that uridylated Rmrp transcripts should accumulate
in the cytoplasm of Dis3l2-deficient cells. To test this, cell frac-
tionation was performed on two control ESC lines as well as
two Dis3l2 knockout cells and nuclear and cytoplasmic RNAs
were analyzed by qRT-PCR. As expected, Gapdh mRNA was
predominantly detected in cytoplasmic fractions, whereas U6
and Rmrp were mainly detected in the nuclear RNA fraction (Fig-
ure 2E). Similar to the pre-let-7g positive control, relative uridyla-
tion of Rmrp was consistently increased up to 100-fold in the
cytoplasmic fraction of two independent Dis3l2 knockout
ESC lines (Figure 2F). Northern blot analysis performed on cyto-
plasmic RNA samples provided further support for specific
accumulation of an extended, slower migrating, Rmrp transcript
(but not 7SK or Rpph1 RNAs) in only Dis3l2-deficient cells
(Figure 2G).
Rmrp Uridylation Occurs on Transcripts with Imprecise
30 Ends
Next, we asked whether the Rmrp tails that Dis3l2 recognizes
are indeed poly-U oligonucleotides at 30 end of Rmrp. To answer
this, we first tested if oligo-dA(12) primers could recognize
oligo-U stretches at 30 end; cDNA preparation from cytoplasmic
RNAs by oligo-dA(12) and PCR amplification of cDNAs using
Rmrp-specific primers and gel electrophoresis revealed a single
band of <300 bp PCR product in Dis3l2 knockout samples,
which was absent in control cells (Figure S3A). Sanger
sequencing confirmed the identity of this PCR product to be cor-
responding to the full-length Rmrp (data not shown). Next, we
used an oligo-dA(12) adaptor oligonucleotide to synthesize
cDNA from cytoplasmic RNA of ESCs and then performed
PCR with Rmrp- and adaptor-specific primers (Figure S3B).
Similarly, gel electrophoresis resolved a single expected band
of 100 bp PCR product solely in Dis3l2 knockout samples,
thereby supporting that uridylation occurred at the 30 end of
Rmrp.(C) Anti-Dis3l2 western blotting of wild-type and knockout ESCs, transiently tran
(D) Wild-type Dis3l2 re-expression in knockout cells significantly decreased the
(E) qRT-PCR confirmation of cytoplasmic (Cyto) and nuclear (Nuc) fractionation
(F) Increased relative uridylation of Rmrp and pre-let-7g in the cytoplasm of Dis3
(G) Northern blot analysis of cytoplasmic RNAs in ESCs. Note to the slowly migrat
were observed in cytoplasmic fraction of Dis3l2 knockout ESCs. Where related, s
0.0001, Student’s t test.
See also Figure S2.To determine the sequence identity of Rmrp tail in Dis3l2
knockout ESCs at single nucleotide resolution, we performed
rapid amplification of cDNA ends from circularized RNA samples
(cRACE). To this end, cytoplasmic RNA from Dis3l2 knockout
ESCs, as well as input, and mutant Dis3l2-IP RNA samples
were isolated and then circularized using T4 RNA ligase. Reverse
transcription (RT) of RNA transcripts with Rmrp-specific primers
followed by PCR reaction using divergent forward and reverse
Rmrp-specific primers yielded a chimeric PCR product that spe-
cifically originated from circularized RNAs and contained the
30 tail sequence (Figure 3A). Sanger sequencing of this PCR
product revealed Rmrp containing oligo-U tails of five and nine
nucleotides long in cytoplasmic Dis3l2 knockout samples (Fig-
ure S3C). More comprehensively, Mi-Seq analysis of chimeric
PCR products from input and IP samples identified the oligo-U
tails at 30 end of Rmrp that were distinguishable from Rmrp
genomic sequence (Figure 3B). In IP samples, Rmrp tails of up
to 26 continuous Uridines were detected, with a peak length dis-
tribution of 10–12 nucleotides. Intriguingly, this peak U-tail length
is highly consistent with the structural basis for Dis3l2 interaction
with the oligo-U tail of pre-let-7 (Faehnle et al., 2014) (Figure 3B).
Moreover, the length and proportion of Rmrp U-tails were sig-
nificantly higher in IP samples compared to input, suggesting
specific enrichment of these tails in mutant Dis3l2-IP. A closer
inspection of this sequencing data intriguingly revealed that
almost all the U-tails of both input and IP transcripts occurred
two nucleotides after annotated 30 end of Rmrp (Figure 3C).
This raised the possibility that Rmrp uridylation might occur
mainly on transcripts containing extra nucleotides at their 30
ends perhaps caused by inaccurate transcription termination.
This observation promoted us to examine the exact 30 end of
Rmrp in both input and IP RNA samples. Surprisingly, only a
small fraction of Rmrp species in input ended with the anno-
tated Cytosine nucleotide (5.7%), whereas, more than 85% of
Rmrp transcripts had one nucleotide less and ended with aden-
osine (Figure 3D). This indicates that Rmrp transcripts ending in
this adenosine are the predominant species in mouse ESCs
and this might represent the actual 30 end of mouse Rmrp in
ESCs. In contrast, more than 97% of U-tailed Rmrp species
in IP samples were extended by three nucleotides than the
newly established 30 end (Figure 3D). Moreover, in silico RNA-
fold analysis revealed that an additional CAC and five or
more uridines at the 30 end could dramatically alter the pre-
dicted Rmrp secondary structure (Figure S3D). Thus, mutant
Dis3l2 enriches for Rmrp species with U-tails, and this uridyla-
tion occurs mainly on inaccurately terminated Rmrp transcripts.
Together, these data indicate that Dis3l2 might be part of a
quality control pathway responsible for ensuring the fidelity of
the Rmrp 30 end.sfected with mock or wild-type Dis3l2 expressing vectors.
uridylated Rmrp and pre-let-7g transcripts, but not Sox2 (n = 3).
of ESCs (n = 4).
l2-deficient ESCs, but not in nuclear fractions (n = 4).
ing species representing tailed Rmrp. No such tailed 7SK or Rpph1 transcripts
cale bars represent mean ± SEM. *p% 0.05, **p% 0.01, ***p% 0.001, ****p%
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Figure 3. Deep Sequencing Analysis of the 30-End of Rmrp RNA
(A) Schematic protocol for Rmrp cRACE. See the Experimental Procedures for details.
(B) The distribution and length of U-tails in input and FLAG mutant Dis3l2-IP RNAs. Note the 10–12 nucleotide-long peak in the U-tail length in the Dis3l2-bound
Rmrp reads.
(C) Analysis of Rmrp 30 end revealed that U-tails are mainly added to transcripts with two additional nucleotides at their 30 compared to annotated gene.
(D) In input samples, majority of Rmrp species are terminated one nucleotide before the annotated transcript (highlighted in red), while the U-tailed Rmrp reads in
IP samples always end two nucleotides downstream.Zcchc6 and Zcchc11 Are TUTases that Trigger Dis3l2-
Mediated Rmrp Decay
Zcchc6 and Zcchc11 are the two TUTase enzymes respon-
sible for uridylation of pre-let-7 miRNAs. We asked if these
enzymes are also involved in terminal uridylation of Rmrp. In-
dividual and simultaneous knockdown of Zcchc6 and Zcchc11
led to a reduction in the levels of Rmrp and pre-let-7g uridyla-
tion (Figures 4A and 4B). We examined whether recombinant
Zcchc11 (expressed and purified from bacteria) could directly
uridylate Rmrp species with additional CAC at the 30 end.
In vitro transcribed Rmrp+CAC was incubated with increasing
amounts of recombinant Zcchc11 in the presence of radiola-
beled UTP. This showed that Zcchc11 is sufficient to uridy-
late Rmrp in a dose-dependent manner (Figure 4C). Next,
we set out to reconstitute uridylation-dependent Dis3l2-medi-
ated Rmrp decay in vitro. In vitro transcribed radiolabeled
Rmrp+CAC RNAs were subjected to Dis3l2 degradation (using
recombinant Dis3l2 expressed and purified from bacteria) in
the presence or absence of recombinant Zcchc11. Indeed,
Dis3l2-mediated Rmrp degradation was found to be depen-
dent on Zchcc11 thereby demonstrating the TUTase-depen-
dency of Dis3l2-mediated decay and furthermore revealing
the sufficiency of these two proteins for the targeted degrada-
tion of Rmrp in vitro (Figure 4D). Together, our results identify
TUTase-dependent Dis3l2-mediated decay (DMD) as a quality
control pathway that ensures the fidelity of the 30 end of Rmrp
(Figure 4E).1866 Cell Reports 16, 1861–1873, August 16, 2016Dis3l2-Mediated Decay Regulates ncRNAs
Considering that the most enriched RNAs identified in FLAG
mutant Dis3l2 were long noncoding RNAs and that Dis3l2-deple-
tion had no effect on any of the mRNAs we tested (Figure 1C
and data not shown), we next asked whether DMD might be
more generally relevant to certain ncRNAs. RIP-sequencing
reads were initially mapped to a database biased toward the
coding portion of the genome (UCSC), which essentially over-
looked the noncoding component of the transcriptome (Fig-
ure 1C). Therefore, we re-examined RIP-seq data and mapped
the sequencing reads to the annotated noncoding transcripts
(ENSEMBL). Interestingly, this analysis revealed the most en-
riched RNAs in FLAG mutant Dis3l2 samples to be ncRNAs (Fig-
ure 5A; Table S2). This list of Dis3l2-bound RNA predominantly
included RNA Pol III-transcribed lncRNAs including 7SL (the
RNA component of signal recognition particle [SRP]), Rmrp
and Rpph1 (as we initially found), Vaultrc5, several snoRNAs,
RNA Y1, 5S rRNA, as well as RNA Pol II-transcribed noncoding
U1 and U2 snRNA and several other uncharacterized ncRNAs
(Table S2). We next tested whether similar to our findings on
Rmrp, Dis3l2-TUTase axis might also be involved in the regula-
tion of other ncRNAs identified, including the most highly en-
riched transcript, 7SL. RIP-qPCR analysis showed that 7SL,
and especially uridylated 7SL, is associated with FLAG mutant
Dis3l2 (Figure 5B). Increased uridylation of 7SL was observed
in two Dis3l2/ ESC lines by qRT-PCR analysis of total and
cytoplasmic RNA fractions (Figures 5C and 5D) as well as by
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Figure 4. TUTase-Dependent Dis3l2-Mediated Decay of Rmrp
(A) Western blot (left panel) and qRT-PCR analyses confirmed the knockdown of two TUTases, Zcchc6 and Zcchc11, in Dis3l2 knockout ESCs (n = 3).
(B) Individual and combinatorial knockdown of TUTases alleviates relative uridylation of Rmrp and pre-let-7g in Dis3l2 knockout ESCs (n = 3).
(C) In vitro uridylation assay using recombinant Zcchc11 (rZcchc11). In vitro transcribed Rmrp+CAC was incubated with radiolabeled UTP and increasing amounts
of rZcchc11. Reactions were run on TBE-Urea gels and visualized by autoradiography.
(D) In vitro reconstitution of TUTase-dependent Dis3l2-dependent Rmrp decay. In vitro transcribed radiolabeled Rmrp+CACwas incubatedwith a buffer containing
rUTP and, where indicated, rZcchc11 and increasing amounts of recombinant Dis3l2 (rDis3l2).
(E) Amodel representing the function of TUTase-Dis3l2 axis in degradation of aberrant Rmrp. Based on this Dis3l2-mediated decay pathwaymodel, mutant Rmrp
transcripts are exported to the cytoplasm, where they are further uridylated by TUTases, Zcchc6 and Zcchc11, and subsequently degraded by Dis3l2 to eliminate
these nonfunctional species.
Cell Reports 16, 1861–1873, August 16, 2016 1867
AC
F
G H
D E
B
Figure 5. Systematic Analysis of Dis3l2-Bound Noncoding RNAs
(A) Scatter plot of enriched ncRNA transcripts in FLAGmutant Dis3l2 IP compared to Mock IP. cDNA libraries from Figure 1C were aligned to noncoding genome
(see the Experimental Procedures).
(B) qRT-PCR analysis of total and uridylated 7SL immunoprecipitated by FLAG mutant Dis3l2 (n = 3).
(C and D) Increased relative uridylation of 7SL in total cell lysates (C) (n = 3) and in cytoplasmic fractions (D) of Dis3l2-deficient ESCs.
(E) Northern blot analysis of 7SL in ESCs. Note the slowly migrating species in RNA samples from Dis3l2-deficient ESCs.
(F) cRACE analysis of 7SL tails in FLAG mutant Dis3l2 immunoprecipitated RNA samples. Sanger sequencing analysis revealed U-tails of different length in
several clones (shown in red). In some clones, the U-tail occurred after 30-end truncated species (clones 5 and 15, marked in blue).
(G) qRT-PCR revealed that Zcchc6 and Zcchc11 knockdown reduces relative uridylation of 7SL (n = 3).
(H) qRT-PCR showed that re-expression of Dis3l2 rescues the elevated uridylation of 7SL transcripts in Dis3l2 knockout cells (n = 3). Scale bars, mean ± SEM.
*p% 0.05, **p% 0.01, ***p% 0.001, ****p% 0.0001, Student’s t test.
See also Figure S4 and Tables S1 and S2.
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Figure 6. Dis3l2 Targets Uridylated U1 and U2 snRNAs
(A) Relative expression (left) and relative uridylation (right) of U1 (U1-a1) and U2 (U2-10) snRNAs in Dis3l2-depleted ESCs. Scale bars, mean ± SEM (n = 3). *p%
0.05, **p% 0.01, Student’s t test.
(B) Cellular fractionation and qRT-PCR analysis confirming nuclear distribution of U1 and U2.
(C) Increased uridylation levels of U1 and U2 in cytoplasmic fractions of Dis3l2 knockout cells. Scale bars, mean ± SEM (n = 3). *p% 0.05, **p% 0.01, Student’s
t test.
(D) Schematic representation of 30 end-ligation RACE protocol established for U1 and U2 snRNAs.
(E and F) Sanger sequencing analysis of 30-ligation RACE PCR products from FLAG Mutant Dis3l2-bound RNAs revealed frequent clones with non-genomic
U-rich tails in U1 (E) and U2 (F) snRNA species.
See also Table S2.northern blot analysis (Figure 5E). We adapted the cRACE proto-
col for 7SL and examined 30 end of cytoplasmic 7SL in Dis3l2/
ESCs. Sanger sequencing of cRACE chimeric PCR products
showed the presence of U-tails in most (12 out of 15) of the
analyzed clones. Occasionally, these tails occurred in clones
with truncated 30 ends (Figure 5F). Moreover, transient knock-
down of Zcchc6, Zcchc11, or both led to a substantial decrease
in relative uridylation of 7SL in Dis3l2 knockout ESCs (Figure 5G).
Finally, re-expression of Dis3l2 in knockout cells could rescue
relative uridylation of 7SL to a level similar to that of wild-type
cells (Figure 5H). Because the specific U1 and U2 isoforms,U1a1 and U2-10, respectively, were among the most highly
enriched RNAs in the Dis3l2 IP (Table S2), we next examined
the role of Dis3l2 in regulation of U1 and U2 snRNAs. qRT-PCR
analysis showed that, although the total level of these two
snRNAs was unchanged in the Dis3l2 knockout cells, the level
of uridylated U1 and U2 was elevated in both total RNA as well
as in cytoplasmic RNA fractions from Dis3l2 knockout ESCs
compared to wild-type cells (Figures 6A–6C).We next performed
30-ligation RACE analysis of the U1 and U2 snRNAs in FLAG
mutant Dis3l2 IP samples (Figure 6D). Sanger sequencing of
the PCR products resulting from amplification of 30 end junctionsCell Reports 16, 1861–1873, August 16, 2016 1869
revealed several clones with U-rich tails in both U1 (Figure 6E)
and U2 (Figure 6F) Dis3l2-IP samples. Particularly, the tails
occurred on U1 and U2 with extended 30 sequences implying
that DMD targets snRNAs with imprecise 30 ends as part of a
quality control pathway for a set of ncRNAs.
DISCUSSION
Previously, we identified Dis3l2 as the 30-50 exonuclease respon-
sible for recognition and degradation of uridylated pre-let-7
miRNAs (Chang et al., 2013). Accordingly, an oligo-U tail is
necessary and sufficient to target Dis3l2 binding and exonucleo-
lytic activity (Chang et al., 2013; Faehnle et al., 2014). Given that
oligouridylation has been implicated in the metabolism of other
RNAs, and Dis3l2 is expressed in cells that do not co-express
Lin28, it is likely that Dis3l2 has additional substrates other
than pre-let-7. So far, an unbiased identification of Dis3l2 sub-
strate RNAs has proven to be challenging because these
labile RNAs are expected to be difficult to detect in steady-state
RNA samples. Furthermore, sequencing RNA samples of Dis3l2-
depleted cells is likely to uncover many indirect changes in RNA
expression. To address this, we developed an innovative strat-
egy to isolate RNAs that are physically associated with Dis3l2.
This involved expressing a catalytic mutant version of FLAG-
Dis3l2 in Dis3l2-knockout ESCs and performing FLAG-immuno-
purification of Dis3l2-containing ribonucleoprotein complexes
from UV-crosslinked cells. This approach both stabilizes decay
substrates (by Dis3l2 deletion) and enriches for direct Dis3l2
targets (by isolating Dis3l2-bound RNAs).
Using this strategy, we discovered that the majority of Dis3l2-
bound RNA species are ncRNAs that are transcribed by RNA Pol
III (Figures 1C and 5A). Two of the most enriched transcripts in
Dis3l2-IP were the lncRNA components of RNase MRP and
RNase P (Rmrp and Rpph1, respectively) and Rpph1 pseudo-
genes. Analysis of relative uridylation of Rmrp and Rpph1 proved
that Rmrp (but not Rpph1) is a true substrate of Dis3l2 because:
(1) Rmrp uridylation is highly stabilized in Dis3l2-depleted cells;
(2) uridylated Rmrp is mostly localized to cytoplasmic fraction
where Dis3l2 is also normally located; (3) ectopic re-expression
of Dis3l2 in knockout ESCs significantly decreases Rmrp uridy-
lation; (4) deep sequencing analysis revealed oligo-uridylation
of Rmrp 30 ends (interestingly, the peak length of this U-tail is
12 nucleotides that is highly consistent with previous biochem-
ical and structural work for Dis3l2 substrate recognition) (Chang
et al., 2013; Faehnle et al., 2014; Ustianenko et al., 2013); and (5)
the uridylation-dependent Dis3l2-mediated decay of Rmrp could
be recapitulated in vitro using purified recombinant proteins.
Despite this evidence that Rmrp is a bona fide direct target of
Dis3l2, it is notable that the steady-state levels of Rmrp are not
appreciably altered by Dis3l2-depletion. Intriguingly however,
our sequencing analysis of Rmrp 30 ends revealed that the
U-tail is specifically added to Rmrp species containing an addi-
tional three nucleotides downstream of the normal 30 end of
the Rmrp RNA. These extra (CAC) nucleotides are encoded by
the genome and lead us to propose that Dis3l2 serves as a
quality control mechanism for the specific decay of aberrant
(and possibly dysfunctional) Rmrp transcripts with an extended
30 end. 30 Terminal modification was previously reported for a1870 Cell Reports 16, 1861–1873, August 16, 2016subset of human RMRP, where oligoadenylation occurred
on extended RMRP species with few uridines (Goldfarb and
Cech, 2013), further implying post-transcriptional regulation of
RMRP. That Dis3l2 degrades only mutant forms of Rmrp helps
distinguish this from a general decay pathway controlling Rmrp
expression or a biogenesis pathway requiring Dis3l2 for Rmrp
30 end maturation because these should impact all Rmrp tran-
scripts and have a more dramatic effect on overall Rmrp expres-
sion. Interestingly, RMRP is itself a disease-associated gene that
is mutated in cartilage-hair hypoplasia (CHH), an autosomal
recessive disorder characterized by disproportionate short stat-
ure and multiple other developmental phenotypes (Ridanpa¨a¨
et al., 2001). It will be of interest to examine the relationship be-
tween DIS3L2 and RMRP in the context of human disease and
their opposing roles in human fetal growth.
While quality control pathways are well-characterized for cod-
ing mRNAs (Garneau et al., 2007), tRNAs (Hopper and Huang,
2015; Kadaba et al., 2006; Vana´cova´ et al., 2005), and rRNAs
(Dez et al., 2006; LaRiviere et al., 2006), far less is known about
the existence of such mechanisms for other ncRNAs. Quality
control mechanisms have been proposed for truncated (Ishi-
kawa et al., 2014) or mutant forms of U1 snRNA (Shukla and
Parker, 2014) and 7SL in yeast (Leung et al., 2014) to eliminate
aberrant transcripts. Defective U1 snRNAs can be degraded
by both 30-50 exonuclease Rrp6 and decapping and Xrn1-medi-
ated decay (Shukla and Parker, 2014); however, EXOSC10, the
human homolog of Rrp6, is dispensable for U1 quality control
suggesting separate mechanisms in higher eukaryotes (Shukla
and Parker, 2014). In addition, in yeast, Trf4-Air1/2-Mtr4 polya-
denylation complex (TRAMP) serves as a nuclear quality control
mechanism for noncoding RNA (LaCava et al., 2005). It targets a
wide variety of RNAs by addition of four to five adenosine resi-
dues and marks them for degradation by the nuclear exosome
(reviewed in Wolin et al., 2012). TRAMP polyadenylates 30 end
of aberrant 23S rRNA intermediates, truncated 5S rRNAs, 7SL,
and some tRNAs. By contrast, such 30 aberrant RNAs that accu-
mulate in yeast upon TRAMP/exosome depletion (including 7SL)
are not found in mammals, thus suggesting different pathways in
metazoans. Particularly, in line with increased repertoire and
complexity of ncRNA genome in evolution (Kapusta and Fes-
chotte, 2014; Mattick, 2011; Rinn and Chang, 2012), there is a
special demand for ncRNA-specific quality control pathway(s)
in mammals. We extend our findings on Rmrp and examine the
role of Dis3l2 in ncRNA regulation more generally. This revealed
a strong enrichment for transcripts that are transcribed by RNA
Pol III. RNA Pol III nascent transcripts harbor additional uridine
residues at their 30 end, which might make them favored sub-
strates for further uridylation by TUTase. Also of relevance, it
was shown that recombinant Zcchc11 (TUT4) displays greater
in vitro TUTase activity toward substrate RNAs without or with
short A-tails compared to longer poly-A-tail-containing RNAs
(Lim et al., 2014). This likely helps explain the involvement of
Zcchc6 and Zcchc11 in the uridylation of Rmrp and 7SL and
the specificity of Dis3l2 for Pol III transcripts and certain non-
polyadenylated Pol II transcripts including snRNAs. Zcchc6
and Zcchc11 TUTases are localized mainly in the cytoplasm
and are therefore physically sequestered from Rmrp. Aber-
rant Rmrp species must be transferred to the cytoplasm by a
yet-to-be-determined export mechanism. This differential sub-
cellular localization may confer TUTase specificity toward those
exported Rmrp molecules. In line with this, it has been shown
that unlike wild-type Rmrp that is retained in the nucleus when
microinjected into rat kidney cells, mutant Rmrp RNA is ex-
ported to the cytoplasm, thereby further highlighting the impor-
tance of both intact sequence and proper localization for Rmrp
function (Jacobson et al., 1995). Although we found a robust
interaction between Dis3l2 and lincRNA ribozyme Rpph1, we
did not find evidence for Rpph1 uridylation in Dis3l2 knockout
cells. Further investigation is required to elucidate biological
significance of Dis3l2-Rpph1 interaction. One possibility is that
Dis3l2 and Rpph1 form a ribonucleoprotein complex, where
the exonuclease activity of Dis3l2 and endonucleolytic activity
of Rpph1 are coupled for tRNA maturation and/or decay.
Our unbiased identification and characterization of Dis3l2
substrate RNAs uncovers a heretofore unknown ncRNA quality
control pathway and paves the way for future studies aimed at
elucidating the particular pathological RNAs and mechanisms
associated with Dis3l2 deficiency during fetal development and
cancer, including Wilms tumors.
EXPERIMENTAL PROCEDURES
Cell Culture
TC1 mouse embryonic stem cells (ESCs) were maintained as previously
described (Pirouz et al., 2015). Briefly, ESCs were adapted to gelatin cultures
and fed with KO-DMEM (Gibco) supplemented with 15% stem cell-qualified
fetal bovine serum (FBS, Gemini), L-glutamine (2 nM, Gibco), HEPES
(20 mM, Gibco), sodium pyruvate (1 mM, Gibco), non-essential amino acids
(0.1 mM each, Gibco), 2-mercaptoethanol (100mM, Sigma), penicillin/strepto-
mycin (104 U/ml, Gibco), and mLIF (103 U/ml, Gemini).
Transfections
For rescue experiments, 1 mgwild-typeDis3l2 expressing vectors or empty vec-
tors (as mock) were reverse transfected by Lipofectamine 2000 (Invitrogen) into
ESCs.Cells were harvested 48–72hr post-transfection andanalyzed bywestern
blotting or qRT-PCR. Dis3l2 stable knockdown ESCs (shDis3l2 lines) were
generatedpreviously (Changetal., 2013). For transient knockdownexperiments,
following ON-TARGET plus siRNAs (all Dharmacon) were used: Control siRNA
pool (D-001810-10), siDis3l2 pool (L-054755-01), siZcchc6 (L-056770-01), and
siZcchc11 pool (L-065226-00). Reverse transfections were performed using
siRNAs and Lipofectamine RNAiMax (Invitrogen) complexes prepared in Opti-
MEM (Gibco). Cells were harvested for analysis 48–72 hr after transfection.
CRISPR/Cas9-Mediated Editing of Dis3l2 Locus
Dis3l2-specific guide RNAs (Figure S1) were designed (http://crispr.mit.edu/)
and cloned into px330 vectors expressing wild-type Cas9 (Addgene) and
used to transect TC1 ESCs. The complete procedure is explained in the Sup-
plemental Information.
RNA Immunoprecipitation and Sequencing
ESCs were first transfected with either FLAG-wild-type Dis3l2, FLAG mutant
Dis3l2, or empty pFLAG-CMV2 (as mock) vectors (Chang et al., 2013). 48 hr
after transfection, cells were washed twice with PBS and UV-crosslinked at
400 J/cm2 energy. Crosslinked cells were lysed in 1 ml protein lysis buffer sup-
plemented with Complete EDTA-free protease inhibitor cocktail (Roche) and
400 U RNaseOUT (Invitrogen) and then treated with RQ1 DNase for 30 min
at 37C. Lysates were centrifuged at 12,000 3 g and the supernatants were
collected. One percent of the lysates were set aside as inputs. For immunopre-
cipitation (IP) of FLAG-tagged Dis3l2, anti-FLAGM2 Affinity Gel beads (Sigma)
were washed three times in CLIP buffer (0.1%SDS, 0.5%NP-40 in 13Mg/Ca-
free PBS). Lysates from an equivalent of 33 107 cells were used for each IPreaction and incubated with 50 ml pre-washed beads for 2–3 hr rotating at 4C.
Beads were then centrifuged at 2,5003 g for 3min andwashed four timeswith
cold CLIP buffer and subsequently four times with high-salt wash buffer (0.1%
SDS, 0.5% NP-40 in 53 Mg/Ca-free PBS) at room temperature. After the last
wash, 10% of the immunoprecipitates were set aside to check IP efficiency by
western blotting. The rest of the beads were re-suspended with protein lysis
buffer containing 100 mg Proteinase K (Ambion) and incubated at 45C
for 45 min for reverse crosslinking and then subjected to RNA extraction.
Approximately 100 ng of immunoprecipitated RNA from inputs or IP samples
were used for cDNA synthesis using random hexamers or oligo-dA oligonucle-
otides, or alternatively for RNA library preparation. RNA library preparation was
performed on IP samples and RiboMinus (Ambion)-selected inputs following
TruSeq Standard mRNA Sample Preparation Guide (Illumina). Libraries were
subjected to Illumina high-throughput sequencing.
Amplification of the Rmrp 30 End and cRACE
Cytoplasmic RNA samples from ESCs were reverse transcribed using oligo-
dA(12) adapters and amplified with Rmrp-specific forward and adaptor-spe-
cific primers (Table S3). PCR products were resolved in 2% agarose gels
and visualized. RNA samples of cytoplasmic (2 mg) or FLAG mutant Dis3l2 IP
(100 ng) were circularized with 1 ml T4 RNA ligase I (NEB), 10 mM ATP
(NEB), 10% PEG 8000 in 13 T4 RNA ligase buffer for 2 hr at 37C, and then
the ligase was inactivated for 5 min at 95C. Circularized RNAs were precipi-
tated with acidic phenol-chloroform (Ambion) and washed with 70% ethanol.
Purified circular RNAs were reverse transcribed with Rmrp- or 7SL-specific
reverse primers (Table S3) and SuperScript III. One-tenth of cDNAs were
further amplified with appropriate Rmrp- or 7SL-specific cRACE-forward
and cRACE-reverse primers (Table S3) and AccuPrime GC-rich DNA Polymer-
ase (Invitrogen) to generated chimeric PCR products corresponding to 50 and
30 ends of related transcripts (Figure 3A). These PCR products were separated
on 2% agarose gel and the bands of correct sizes were gel-extracted, purified,
and used in library preparation for MiSeq analysis using TruSeq Stranded
mRNA Sample Preparation Kits (Illumina). In order to perform Sanger
sequencing analysis of cRACE products, before size selection on agarose
gel, reactions were treated with Taq polymerase (Invitrogen) for 20 min at
72C. This incorporated an ‘‘A’’ overhang to PCR product andmade them suit-
able for TA-cloning in pGEM-T easy vectors (Promega). Positive clones were
analyzed by Sanger sequencing to identify 30 ends of Rmrp and 7SL.
30 End Ligation RACE
After RNA isolation of FLAG mutant Dis3l2 IP samples, 100 ng RNAs were
ligated overnight at 25C to 2 mMUniversal miRNA Cloning Linker (NEB) using
200 U of T4 RNA ligase 2 truncated KQ (NEB) at the presence of 25% PEG
8000 and RNaseOUT. Ligated RNAswere purified using RNAClean &Concen-
trator-25 columns (Zymo Research) and reverse transcribed by SuperScript III
(see RNA extraction and qRT-PCR section) and universal RT+linker primer
(Table S3). cDNAs were diluted and 100 ng cDNA was used for PCR reaction
using U1 and U2 gene-specific forward primers (Table S3) and universal
RT+linker reverse primer. PCR products were gel-extracted and cloned into
pGEM-T easy vectors (Promega) and sequenced by Sanger sequencing.
Statistics
All the experiments were performed for at least three times. For quantitative
data, mean values ± SEMwere plotted. Student’s t tests were used to analyze
the significance of difference between different groups.
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